Mar 6, 2026 02:13PM
Mar 5, 2026 11:55AM
Mar 4, 2026 04:27PM
Mar 4, 2026 04:05PM
Feb 18, 2026 04:05PM
Jan 13, 2026 07:06AM
Jan 13, 2026 07:05AM Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
Nov 6, 2025 04:27PM
Nov 6, 2025 04:05PM
Oct 23, 2025 04:05PM
Oct 17, 2025 07:01AM
Oct 17, 2025 07:00AM
Aug 7, 2025 04:21PM
Aug 7, 2025 04:05PM Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
Jul 24, 2025 04:05PM
May 8, 2025 04:20PM
May 8, 2025 04:05PM
Apr 24, 2025 04:05PM
Mar 5, 2025 04:12PM
Mar 5, 2025 04:05PM
Feb 19, 2025 04:05PM Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025
Jan 14, 2025 08:07AM
Jan 14, 2025 08:00AM
Nov 8, 2024 06:58AM
Nov 7, 2024 04:05PM
Nov 4, 2024 09:06AM
Oct 17, 2024 04:05PM
Aug 1, 2024 04:24PM Sight Sciences, Inc. (SGHT) Tops Q2 EPS by 5c, narrows guidance
Aug 1, 2024 04:05PM
Jul 18, 2024 04:05PM
May 2, 2024 04:50PM
May 2, 2024 04:05PM
Apr 18, 2024 04:05PM
Mar 7, 2024 04:20PM
Mar 7, 2024 04:05PM Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
Feb 22, 2024 04:05PM
Feb 14, 2024 04:05PM
Jan 8, 2024 04:08PM
Jan 8, 2024 04:05PM
Nov 7, 2023 04:33PM
Nov 7, 2023 04:05PM
Oct 26, 2023 05:29PM Sight Sciences (SGHT) evaluating 2023 guidance due to "uncertain impact of reimbursement coverage for Surgical Glaucoma segment"
Oct 24, 2023 04:05PM
Sep 11, 2023 04:06PM
Aug 3, 2023 04:55PM
Aug 3, 2023 04:05PM
Jul 20, 2023 04:05PM
Jul 20, 2023 08:34AM
Jul 20, 2023 08:30AM Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA, a Randomized Controlled Clinical Trial Comparing Interventional Eyelid Procedures Enabled by TearCare® Techn
Jun 21, 2023 08:36AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All